Pakistan, June 5 -- Scientists have developed a new experimental vaccine designed by artificial intelligence that aims to protect humans against a wide range of deadly viruses. Researchers say this is the first time an AI-designed vaccine has been tested in human trials, marking a major step in vaccine development. Moreover, the study focused on viruses linked to past global outbreaks such as SARS, MERS, and Covid-19. Early findings show cautious but promising scientific progress.

The trial was conducted by researchers at the University of Cambridge, involving nearly 40 participants between 2021 and 2023. In addition, scientists described the vaccine as a "universal vaccine" concept designed to target multiple virus families rather than ...